Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Effect of Ischemic Preconditioning on Endurance Performance Does Not Surpass Placebo

Full text
Author(s):
Sabino-Carvalho, Jeann L. ; Lopes, Thiago R. ; Obeid-Freitas, Tiago ; Ferreira, Thiago N. ; Succi, Jose E. ; Silva, Antonio C. ; Silva, Bruno M.
Total Authors: 7
Document type: Journal article
Source: MEDICINE AND SCIENCE IN SPORTS AND EXERCISE; v. 49, n. 1, p. 124-132, JAN 2017.
Web of Science Citations: 25
Abstract

Purpose: Recent studies have reported ischemic preconditioning (IPC) can acutely improve endurance exercise performance in athletes. However, placebo and nocebo effects have not been sufficiently controlled, and the effect on aerobic metabolism parameters that determine endurance performance (e. g., oxygen cost of running, lactate threshold, and maximal oxygen uptake {[}(V)over dotO(2max)]) has been equivocal. Thus, we circumvented limitations from previous studies to test the effect of IPC on aerobic metabolism parameters and endurance performance in well-trained runners. Methods: Eighteen runners (14 men/4 women) were submitted to three interventions, in random order: IPC; sham intervention (SHAM); and resting control (CT). Subjects were told both IPC and SHAM would improve performance compared to CT (i. e., similar placebo induction), and IPC would be harmless despite circulatory occlusion sensations (i. e., nocebo avoidance). Next, pulmonary ventilation and gas exchange, blood lactate concentration, and perceived effort were measured during a discontinuous incremental test on a treadmill. Then, a supramaximal test was used to verify the (V)over dotO(2max) and assess endurance performance (i. e., time to exhaustion). Results: Ventilation, oxygen uptake, carbon dioxide output, lactate concentration, and perceived effort were similar among IPC, SHAM, and CT throughout the discontinuous incremental test (P > 0.05). Oxygen cost of running, lactate threshold, and (V)over dotO(2max) were also similar among interventions (P > 0.05). Time to exhaustion was longer after IPC (mean +/- SEM, 165.34 +/- 12.34 s) and SHAM (164.38 +/- 11.71 s) than CT (143.98 +/- 12.09 s; P = 0.02 and 0.03, respectively), but similar between IPC and SHAM (P = 1.00). Conclusions: IPC did not change aerobic metabolism parameters, whereas improved endurance performance. The IPC improvement, however, did not surpass the effect of a placebo intervention. (AU)

FAPESP's process: 14/15877-8 - Effect of ischemic preconditioning on mechanisms that determine the aerobic performance in high level runners
Grantee:Jeann Luccas de Castro Sabino de Carvalho
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 15/03572-0 - Effect of ischemic preconditioning of the lower limbs on cardiac autonomic recovery after exercise in middle/long distance runners
Grantee:Tiago Obeid de Freitas
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 14/24294-6 - Tonic contribution of the peripheral chemoreflex to the vagal control of the heart at rest and recovery from exercise in patients with chronic heart failure
Grantee:Bruno Moreira Silva
Support Opportunities: Regular Research Grants